Evidence map›Paper›PMID 41583235›Full record

ReviewCureus2025

Advancing Health Equity Through Telepharmacy Antimicrobial Stewardship in Rural Communities in the United States.

Adeola Bakare, Patrick Oliorah, Daniel O Umoru, Chidinma V Muoghalu, Mary-Jane E Ugbor, Rebecca Omachonu

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adeola BakarePharmacy, Citiserve Pharmacy Ltd, Lagos, NGA.
Patrick OliorahCollege of Pharmaceutical Sciences, University of Nigeria Nsukka, Enugu, NGA.
Daniel O UmoruPharmacy, National Hospital Abuja, Abuja, NGA.
Chidinma V MuoghaluBiochemistry and Nutrition, Nigeria Institute of Medical Research, Lagos, NGA.
Mary-Jane E UgborPharmaceutical Sciences, University of PortHarcourt, PortHarcourt, NGA.
Rebecca OmachonuPharmacy, Keck Graduate Institute of Applied Life Sciences, Claremont, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance remains a growing global threat, disproportionately impacting underserved rural communities in the United States with limited access to pharmacy services. This meta review synthesizes evidence on community-led telepharmacy antimicrobial stewardship programs and evaluates their impact on antibiotic prescribing practices, resistance patterns, and alignment with Sustainable Development Goals. The objective is to determine the clinical, economic, and equity outcomes associated with telepharmacy-supported stewardship in rural United States healthcare settings. From 8,742 identified records, 20 studies met the inclusion criteria spanning telepharmacy implementation, antimicrobial stewardship outcomes, prescribing patterns, and policy frameworks. Studies published between 2005 and 2021 provided quantifiable metrics on clinical, economic, and equity-related outcomes. Inappropriate antibiotic use decreased by 28.6% (95% CI 21.3 to 35.9, p<0.001), and odds of appropriate prescribing improved significantly (OR 3.21, 95% CI 2.54 to 4.06). Broad spectrum utilization declined by 32.4%, guideline concordant selection improved by 41.2%, medication errors decreased by 94% (OR 0.06, 95 percent CI 0.03 to 0.12), and antibiotic de-escalation rates nearly doubled (34% to 67%). Hospitals integrating telepharmacy stewardship experienced reduced length of stay (mean 1.8 days, 95% CI 1.2 to 2.4, p<0.001) and 41% fewer Clostridium difficile infections (IRR 0.59, 95 percent CI 0.43 to 0.81). Days of therapy per 1,000 patient days decreased by 89.7 days (95% CI 67.2 to 112.3). Programs demonstrated cost savings of 3.45 dollars per dollar invested (95% CI 2.89 to 4.01). Annual savings averaged 487,000 dollars per facility, and cost per prescription decreased by 47.30 dollars. Cost avoidance from prevented resistance-related complications totaled 1.2 million dollars annually per 200-bed facility. Telepharmacy increased rural pharmaceutical care accessibility (OR 2.71, 95% CI 2.03 to 3.62, p<0.001). Preventive service use increased by 23.4%, and equity index scores improved by 18.6 points, demonstrating alignment with Sustainable Development Goals 3 and 10. Program retention reached 83.4% at two years, with provider acceptance of 89.7% and improved staff satisfaction (mean increase 2.2 points, p<0.001). Community-led telepharmacy antimicrobial stewardship programs represent cost-effective interventions that address antimicrobial resistance, improve clinical outcomes, reduce healthcare costs, and advance equity in rural United States communities. Evidence supports broader implementation with attention to regulatory policy, technological capacity, and long-term stakeholder engagement.

Indexed as

antimicrobial resistanceantimicrobial stewardshipdigital healthhealth equityhealth policypharmacypublic health policy interdisciplinary relevance: public healthrural healthcaresustainable development goalstelepharmacy

Identifiers

PMID41583235
PMCPMC12829984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.